Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2014

Open Access 01-12-2014 | Research

The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency

Authors: Zsuzsanna Zotter, Dorottya Csuka, Erika Szabó, Ibolya Czaller, Zsuzsanna Nébenführer, György Temesszentandrási, George Fust, Lilian Varga, Henriette Farkas

Published in: Orphanet Journal of Rare Diseases | Issue 1/2014

Login to get access

Abstract

Background

Hereditary angioedema (HAE) resulting from C1-inhibitor deficiency is characterized by attacks of subcutaneous and submucosal edema. Many factors have been presumed to induce edema. Our study analyzed these factors in a fairly large patient population.

Methods

In the first stage of our study, we analyzed the data recorded by 92 subjects in their patient diaries over seven years. The second phase included 27 HAE patients, who had been completing the diary entry ‘Trigger factors’ every day for seven months whether or not they had experienced an attack.

Results

During the initial stage, 91% of the subjects described some factor possibly related to the onset of an attack. They could identify a trigger factor – most commonly (21%) mental stress – in 30% of the 3176 attacks. We found a significant (p < 0.001) difference in the distribution of the trigger factors of the edematous attacks of different locations. The 27 participants of the second phase identified 882 potential trigger factors and recorded 365 attacks. Of these, 246 (67%) occurred on days when the patients identified a potential trigger factor. The likelihood of edema-formation associated with the latter was as follows: menstruation – 63%, infection – 38%, mental stress – 26%, physical exertion – 25%, meteorological changes – 21%, fatigue – 17%.

Conclusion

This analysis of the trigger factors explored, for the first time, their potential role in inducing HAE attacks. Our findings might open new perspectives in extending the indications for edema-prophylaxis, and could contribute to a better understanding of the pathomechanism of HAE attacks.
Literature
1.
go back to reference van Geffen M, Cugno M, Lap P, Loof A, Cicardi M, van Heerde W: Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency. Clin Exp Immunol. 2012, 167 (3): 472-478. 10.1111/j.1365-2249.2011.04541.x.CrossRefPubMedPubMedCentral van Geffen M, Cugno M, Lap P, Loof A, Cicardi M, van Heerde W: Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency. Clin Exp Immunol. 2012, 167 (3): 472-478. 10.1111/j.1365-2249.2011.04541.x.CrossRefPubMedPubMedCentral
2.
go back to reference Kaplan AP: Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy. J Allergy Clin Immunol. 2010, 126 (5): 918-925. 10.1016/j.jaci.2010.08.012.CrossRefPubMed Kaplan AP: Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy. J Allergy Clin Immunol. 2010, 126 (5): 918-925. 10.1016/j.jaci.2010.08.012.CrossRefPubMed
3.
go back to reference Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C, Farkas H, Fáy K, Fekete B, Fischer B, Fontana L, Füst G, Giacomelli R, Gröner A, Hack CE, Harmat G, Jakenfelds J, Juers M, Kalmár L, Kaposi PN, Karádi I, Kitzinger A, Kollár T, et al: Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004, 114 (3 Suppl): S51-S131.CrossRefPubMed Agostoni A, Aygören-Pürsün E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C, Farkas H, Fáy K, Fekete B, Fischer B, Fontana L, Füst G, Giacomelli R, Gröner A, Hack CE, Harmat G, Jakenfelds J, Juers M, Kalmár L, Kaposi PN, Karádi I, Kitzinger A, Kollár T, et al: Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol. 2004, 114 (3 Suppl): S51-S131.CrossRefPubMed
4.
go back to reference Longhurst H, Cicardi M: Hereditary angio-oedema. Lancet. 2012, 379 (9814): 474-481. 10.1016/S0140-6736(11)60935-5. doi: 10.1016/S0140-6736(11)60935-5CrossRefPubMed Longhurst H, Cicardi M: Hereditary angio-oedema. Lancet. 2012, 379 (9814): 474-481. 10.1016/S0140-6736(11)60935-5. doi: 10.1016/S0140-6736(11)60935-5CrossRefPubMed
5.
go back to reference Bork K, Hardt J, Witzke G: Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012, 130 (3): 692-697. 10.1016/j.jaci.2012.05.055.CrossRefPubMed Bork K, Hardt J, Witzke G: Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012, 130 (3): 692-697. 10.1016/j.jaci.2012.05.055.CrossRefPubMed
6.
go back to reference Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, Aygoeren-Pürsün E, Craig T, Binkley K, Hebert J, Ritchie B, Bouillet L, Betschel S, Cogar D, Dean J, Devaraj R, Hamed A, Kamra P, Keith PK, Lacuesta G, Leith E, Lyons H, Mace S, Mako B, Neurath D, Poon MC, Rivard GE, Schellenberg R, Rowan D, Rowe A, et al: 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010, 6 (1): 24-10.1186/1710-1492-6-24.CrossRefPubMedPubMedCentral Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, Aygoeren-Pürsün E, Craig T, Binkley K, Hebert J, Ritchie B, Bouillet L, Betschel S, Cogar D, Dean J, Devaraj R, Hamed A, Kamra P, Keith PK, Lacuesta G, Leith E, Lyons H, Mace S, Mako B, Neurath D, Poon MC, Rivard GE, Schellenberg R, Rowan D, Rowe A, et al: 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010, 6 (1): 24-10.1186/1710-1492-6-24.CrossRefPubMedPubMedCentral
7.
go back to reference Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A, Zuraw B, HAWK (Hereditary Angioedema International Working Group): Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy. 2012, 67 (2): 147-157. 10.1111/j.1398-9995.2011.02751.x.CrossRefPubMed Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A, Zuraw B, HAWK (Hereditary Angioedema International Working Group): Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy. 2012, 67 (2): 147-157. 10.1111/j.1398-9995.2011.02751.x.CrossRefPubMed
8.
go back to reference Craig T, Aygören-Pürsün E, Bork K, Bowen T, Boysen H, Farkas H, Grumach A, Katelaris CH, Lockey R, Longhurst H, Lumry W, Magerl M, Martinez-Saguer I, Ritchie B, Nast A, Pawankar R, Zuraw B, Maurer M: WAO Guideline for the Management of Hereditary Angioedema. World Allergy Organ J. 2012, 5 (12): 182-199. 10.1097/WOX.0b013e318279affa.CrossRefPubMedPubMedCentral Craig T, Aygören-Pürsün E, Bork K, Bowen T, Boysen H, Farkas H, Grumach A, Katelaris CH, Lockey R, Longhurst H, Lumry W, Magerl M, Martinez-Saguer I, Ritchie B, Nast A, Pawankar R, Zuraw B, Maurer M: WAO Guideline for the Management of Hereditary Angioedema. World Allergy Organ J. 2012, 5 (12): 182-199. 10.1097/WOX.0b013e318279affa.CrossRefPubMedPubMedCentral
9.
go back to reference Freiberger T, Grombiříková H, Ravčuková B, Jarkovský J, Kuklínek P, Kryštůfková O, Hanzlíková J, Daňková E, Kopecký O, Zachová R, Lahodná M, Vašáková M, Grodecká L, Litzman J: No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene. Scand J Immunol. 2011, 74 (1): 100-106. 10.1111/j.1365-3083.2011.02547.x.CrossRefPubMed Freiberger T, Grombiříková H, Ravčuková B, Jarkovský J, Kuklínek P, Kryštůfková O, Hanzlíková J, Daňková E, Kopecký O, Zachová R, Lahodná M, Vašáková M, Grodecká L, Litzman J: No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene. Scand J Immunol. 2011, 74 (1): 100-106. 10.1111/j.1365-3083.2011.02547.x.CrossRefPubMed
10.
go back to reference Kalmár L, Hegedüs T, Farkas H, Nagy M, Tordai A: HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene. Hum Mutat. 2005, 25 (1): 1-5. 10.1002/humu.20112.CrossRefPubMed Kalmár L, Hegedüs T, Farkas H, Nagy M, Tordai A: HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene. Hum Mutat. 2005, 25 (1): 1-5. 10.1002/humu.20112.CrossRefPubMed
11.
go back to reference Bors A, Csuka D, Varga L, Farkas H, Tordai A, Füst G, Szilagyi A: Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations. J Allergy Clin Immunol. 2013, 131 (6): 1708-1711. 10.1016/j.jaci.2012.11.015.CrossRefPubMed Bors A, Csuka D, Varga L, Farkas H, Tordai A, Füst G, Szilagyi A: Less severe clinical manifestations in patients with hereditary angioedema with missense C1INH gene mutations. J Allergy Clin Immunol. 2013, 131 (6): 1708-1711. 10.1016/j.jaci.2012.11.015.CrossRefPubMed
12.
go back to reference Kaplan AP, Ghebrehiwet B: The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol. 2010, 47 (13): 2161-2169. 10.1016/j.molimm.2010.05.010.CrossRefPubMed Kaplan AP, Ghebrehiwet B: The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol. 2010, 47 (13): 2161-2169. 10.1016/j.molimm.2010.05.010.CrossRefPubMed
13.
go back to reference Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffré D, Nussberger J: Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology. 1999, 44 (1–2): 21-25.CrossRefPubMed Agostoni A, Cicardi M, Cugno M, Zingale LC, Gioffré D, Nussberger J: Angioedema due to angiotensin-converting enzyme inhibitors. Immunopharmacology. 1999, 44 (1–2): 21-25.CrossRefPubMed
14.
go back to reference Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G: Nonallergic angioedema: role of bradykinin. Allergy. 2007, 62 (8): 842-856. 10.1111/j.1398-9995.2007.01427.x.CrossRefPubMed Bas M, Adams V, Suvorava T, Niehues T, Hoffmann TK, Kojda G: Nonallergic angioedema: role of bradykinin. Allergy. 2007, 62 (8): 842-856. 10.1111/j.1398-9995.2007.01427.x.CrossRefPubMed
15.
go back to reference Farkas H, Füst G, Fekete B, Karádi I, Varga L: Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Lancet. 2001, 358 (9294): 1695-1696. 10.1016/S0140-6736(01)06720-4.CrossRefPubMed Farkas H, Füst G, Fekete B, Karádi I, Varga L: Eradication of Helicobacter pylori and improvement of hereditary angioneurotic oedema. Lancet. 2001, 358 (9294): 1695-1696. 10.1016/S0140-6736(01)06720-4.CrossRefPubMed
17.
go back to reference Bouillet L, Launay D, Fain O, Boccon-Gibod I, Laurent J, Martin L, Montauban V, Finck K, Bouée S, Gompel A, Kanny G: French National Reference Center for Hereditary Angioedema (CREAK). Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients. Ann Allergy Asthma Immunol. 2013, 111 (4): 290-294. 10.1016/j.anai.2013.07.012.CrossRefPubMed Bouillet L, Launay D, Fain O, Boccon-Gibod I, Laurent J, Martin L, Montauban V, Finck K, Bouée S, Gompel A, Kanny G: French National Reference Center for Hereditary Angioedema (CREAK). Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients. Ann Allergy Asthma Immunol. 2013, 111 (4): 290-294. 10.1016/j.anai.2013.07.012.CrossRefPubMed
18.
go back to reference Jolles S, Williams P, Carne E, Mian H, Huissoon A, Wong G, Hackett S, Lortan J, Platts V, Longhurst H, Grigoriadou S, Dempster J, Deacock S, Khan S, Darroch J, Simon C, Thomas M, Pavaladurai V, Alachkar H, Herwadkar A, Abinun M, Arkwright P, Tarzi M, Helbert M, Bangs C, Pastacaldi C, Phillips C, Bennett H, El-Shanawany T: A UK national audit of hereditary and acquired angioedema. Clin Exp Immunol. 2014, 175 (1): 59-67. 10.1111/cei.12159.CrossRefPubMedPubMedCentral Jolles S, Williams P, Carne E, Mian H, Huissoon A, Wong G, Hackett S, Lortan J, Platts V, Longhurst H, Grigoriadou S, Dempster J, Deacock S, Khan S, Darroch J, Simon C, Thomas M, Pavaladurai V, Alachkar H, Herwadkar A, Abinun M, Arkwright P, Tarzi M, Helbert M, Bangs C, Pastacaldi C, Phillips C, Bennett H, El-Shanawany T: A UK national audit of hereditary and acquired angioedema. Clin Exp Immunol. 2014, 175 (1): 59-67. 10.1111/cei.12159.CrossRefPubMedPubMedCentral
19.
go back to reference Bygum A: Hereditary angio-oedema in Denmark: a nationwide survey. Br J Dermatol. 2009, 161 (5): 1153-1158. 10.1111/j.1365-2133.2009.09366.x.CrossRefPubMed Bygum A: Hereditary angio-oedema in Denmark: a nationwide survey. Br J Dermatol. 2009, 161 (5): 1153-1158. 10.1111/j.1365-2133.2009.09366.x.CrossRefPubMed
20.
go back to reference Füst G, Farkas H, Csuka D, Varga L, Bork K: Long-term efficacy of danazol treatment in hereditary angioedema. Eur J Clin Invest. 2011, 41 (3): 256-262. 10.1111/j.1365-2362.2010.02402.x.CrossRefPubMed Füst G, Farkas H, Csuka D, Varga L, Bork K: Long-term efficacy of danazol treatment in hereditary angioedema. Eur J Clin Invest. 2011, 41 (3): 256-262. 10.1111/j.1365-2362.2010.02402.x.CrossRefPubMed
Metadata
Title
The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency
Authors
Zsuzsanna Zotter
Dorottya Csuka
Erika Szabó
Ibolya Czaller
Zsuzsanna Nébenführer
György Temesszentandrási
George Fust
Lilian Varga
Henriette Farkas
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2014
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-9-44

Other articles of this Issue 1/2014

Orphanet Journal of Rare Diseases 1/2014 Go to the issue